Sound Shore Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-927,794
Closed -$155M 40
2019
Q2
$155M Sell
927,794
-65,525
-7% -$9.07M 3.01% 14
2019
Q1
$145M Sell
993,319
-21,494
-2% -$3.12M 2.8% 15
2018
Q4
$136M Buy
1,014,813
+279,693
+38% +$45.8M 2.79% 17
2018
Q3
$140M Buy
+735,120
New +$135M 2.39% 25
2017
Q4
Sell
-781,069
Closed -$160M 42
2017
Q3
$160M Sell
781,069
-12,302
-2% -$2.86M 2.61% 21
2017
Q2
$193M Buy
793,371
+94,923
+14% +$22.3M 3.16% 8
2017
Q1
$167M Sell
698,448
-5,956
-0.8% -$1.39M 2.77% 19
2016
Q4
$148M Buy
+704,404
New +$146M 2.55% 27

Other funds holding AGN

Sound Shore Management's AGN Position: Q3 2019 in Review

Sound Shore Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 927,794 shares — an estimated $155M sold.

Sound Shore Management first reported a position in AGN in Q4 2016 and held it in 8 quarters. The position peaked at $193M in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Sound Shore Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Sound Shore Management sold 927,794 Allergan plc shares in Q3 2019, an estimated $155M.
  • Sound Shore Management first reported a position in Allergan plc in Q4 2016 and held it in 8 quarters.
  • Sound Shore Management's Allergan plc position peaked at $193M in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Sound Shore Management's 13F filing for Q3 2019, filed 8 Nov 2019.